Day: October 29, 2025

Cyclo Therapeutics’ TransportNPC™ Phase 3 clinical trial for Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1, a rare and fatal genetic disease, is continuing at the recommendation of the Data Monitoring Committee (DMC) following their review of prespecified safety and efficacy date at 48 weeks On August 4, 2025, Joshua Fine was elected as the Company’s Chief Operating Officer NEWARK, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) — Rafael Holdings, Inc. (NYSE: RFL; NYSE American: RFL-W), today reported its financial results for the fourth quarter and full fiscal year 2025 ended July 31, 2025. “We are pleased with the continued progress of our pivotal Phase 3 TransportNPC™ study evaluating Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1, which we believe could provide an...

EXTON, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) —    OMEGA FLEX, INC. (OFLX)    Nine Months Ended September 30,   Three Months Ended September 30,                       2025     2024     2025     2024                 Net Sales   $ 73,089,000   $ 74,716,000   $ 24,234,000   $ 24,880,000                                  Net Income attributable to Omega Flex, Inc.   $ 11,412,000   $ 13,332,000   $ 3,688,000   $ 4,617,000                                  Earnings Per Share –Basic and Diluted   $ 1.13   $ 1.32   $ 0.37   $ 0.46                                  Weighted Average Shares –Basic and Diluted     10,094,322     10,094,322     10,094,322     10,094,322                 Dean W. Rivest, CEO, announced that net sales of Omega Flex, Inc. (the “Company”) for the first nine months of...

Third Quarter 2025 Total Revenues of $231.1 million, above the high end of Q3 guidance by $21.0 million Third Quarter 2025 Net Income of $51.2 million and Net Income Margin of 22% Third Quarter 2025 Gross Margin % of 54% and Adjusted Gross Margin % of 61%, an expansion of 300 bps and 200 bps, respectively, versus prior year Third Quarter 2025 Adjusted EBITDA of $87.8 million and Adjusted EBITDA Margin of 38% Raising the Full Year 2025 Revenue and Profitability Guidance Strong Sequential Naloxone Revenue Growth, Primarily Driven by NARCAN® Nasal Spray, QoQ Through Q3 2025GAITHERSBURG, Md., Oct. 29, 2025 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the third quarter ended September 30, 2025. “Following a strong second quarter, we are proud to again beat the high end of our third...

HAMILTON, BERMUDA, October 29, 2025 – DHT Holdings, Inc. (NYSE:DHT) (“DHT” or the “Company”) today announced its results for the quarter ended September 30, 2025. The full report is available here and in the below attachment. About DHT Holdings, Inc.DHT is an independent crude oil tanker company. Our fleet trades internationally and consists of crude oil tankers in the VLCC segment. We operate through our wholly owned management companies in Monaco, Norway, Singapore, and India. You may recognize us by our renowned business approach as an experienced organization with focus on first rate operations and customer service; our quality ships; our prudent capital structure that promotes staying power through the business cycles; our fleet employment with a combination of market exposure and fixed income contracts; our disciplined capital allocation...

– Loan Originations of $1.8 Billion –– Net Income of $4.9 Million –– Diluted Earnings Per Share of $0.34 – MURRAY, Utah, Oct. 29, 2025 (GLOBE NEWSWIRE) — FinWise Bancorp (NASDAQ: FINW) (“FinWise”, the “Company”, “we”, “our”, or “us”), parent company of FinWise Bank (the “Bank”), today announced results for the quarter ended September 30, 2025. Third Quarter 2025 HighlightsLoan originations totaled $1.8 billion, compared to $1.5 billion for the quarter ended June 30, 2025, and $1.4 billion for the third quarter of the prior year Net interest income was $18.6 million, compared to $14.7 million for the quarter ended June 30, 2025, and $14.8 million for the third quarter of the prior year Net income was $4.9 million, compared to $4.1 million for the quarter ended June 30, 2025, and $3.5 million...

Dayforce® recurring revenue, excluding float, of $333 million, up 14% on a GAAP and constant currency basis Total revenue of $482 million, up 10%, and excluding float, up 11%, or 12% on a constant currency basis Year-to-date net cash provided by operating activities of $194 million MINNEAPOLIS and TORONTO, Oct. 29, 2025 (GLOBE NEWSWIRE) — Dayforce, Inc. (“Dayforce” or the “Company”) (NYSE:DAY) (TSX:DAY), a global leader in human capital management (“HCM”) technology, today announced its financial results for the third quarter ended September 30, 2025. Financial Highlights for the Third Quarter 20251Total revenue was $481.6 million, an increase of 9.5%, or 9.6% on a constant currency basis. Excluding float, total revenue was $439.4 million, an increase of 11.4%, or 11.6% on a constant currency...

– Record Quarterly Revenue of $278 Million, up 20% Year-over-Year –– Quarterly Net Income of Approximately $15 Million –– Quarterly Adjusted EBITDA of $36 Million, up 54% Year-over-Year –– 46% Monthly-Active-User Growth in the United States and Canada Online Casino Markets –– Raising Full Year 2025 Revenue & Adjusted EBITDA Guidance Ranges, reflecting +20% and +62% growth at each respective midpoint – CHICAGO, Oct. 29, 2025 (GLOBE NEWSWIRE) — Rush Street Interactive, Inc. (NYSE: RSI) (“RSI”), a leading online casino and sports betting company in the United States and the rest of the Americas, today announced financial results for the third quarter ended September 30, 2025. Third Quarter 2025 HighlightsRevenue was $277.9 million during the third quarter of 2025,...

Net Income rose $6.8 million, or 211.5%, to $10.0 million for the quarter ended September 30, 2025 as compared to $3.2 million for the quarter ended September 30, 2024 Net Interest Income increased $4.0 million, or 17.3%, to $27.0 million for the quarter ended September 30, 2025, from $23.0 million for the quarter ended September 30, 2024 Net Interest Margin grew 45 basis points to 4.26% for the quarter ended September 30, 2025, as compared to 3.81% for the quarter ended September 30, 2024 Total Loans grew $119.9 million, or 6.6%, reaching $1.9 billion at September 30, 2025, as compared to $1.8 billion at December 31, 2024. Total Deposits rose $125.5 million, or 5.8%, to $2.3 billion at September 30, 2025, from $2.2 billion at December 31, 2024 Book value per share increased $3.86, or 23.6%, to $20.21 at September 30, 2025, from $16.35...